Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0440 Transporter Info
Gene Name	SLC6A1
Transporter Name	Sodium- and chloride-dependent GABA transporter 1
Gene ID	6529
UniProt ID	P30531

Post-Translational Modification of This DT
Overview of SLC6A1 Modification Sites with Functional and Structural Information
Sequence	M A T N G S K V A D G Q I S T E V S E A P V A N D K P K T L V V K V Q K K A A D L P D R D T W K G R F D F L M S C V G Y A I G L G N V W R F P Y L C G K N G G G A F L I P Y F L T L I F A G V P L F L L E C S L G Q Y T S I G G L G V W K L A P M F K G V G L A A A V L S F W L N I Y Y I V I I S W A I Y Y L Y N S F T T T L P W K Q C D N P W N T D R C F S N Y S M V N T T N M T S A V V E F W E R N M H Q M T D G L D K P G Q I R W P L A I T L A I A W I L V Y F C I W K G V G W T G K V V Y F S A T Y P Y I M L I I L F F R G V T L P G A K E G I L F Y I T P N F R K L S D S E V W L D A A T Q I F F S Y G L G L G S L I A L G S Y N S F H N N V Y R D S I I V C C I N S C T S M F A G F V I F S I V G F M A H V T K R S I A D V A A S G P G L A F L A Y P E A V T Q L P I S P L W A I L F F S M L L M L G I D S Q F C T V E G F I T A L V D E Y P R L L R N R R E L F I A A V C I I S Y L I G L S N I T Q G G I Y V F K L F D Y Y S A S G M S L L F L V F F E C V S I S W F Y G V N R F Y D N I Q E M V G S R P C I W W K L C W S F F T P I I V A G V F I F S A V Q M T P L T M G N Y V F P K W G Q G V G W L M A L S S M V L I P G Y M A Y M F L T L K G S L K Q R I Q V M V Q P S E D I V R P E N G P E Q P Q A G S S T S K E A Y I
PTM type	X-N-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	176
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A1 Asparagine 176 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	181
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A1 Asparagine 181 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	184
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A1 Asparagine 184 has the potential to affect its expression or activity.
Oxidation
Cystine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A1			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	74
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC6A1 Cystine 74 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A1			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	164
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC6A1 Cystine 164 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A1			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	493
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC6A1 Cystine 493 has the potential to affect its expression or activity.
Phosphorylation
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	6
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A1 Serine 6 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A1			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	562
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A1 Serine 562 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A1			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	591
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A1 Serine 591 has the potential to affect its expression or activity.
Threonine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A1			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	3
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A1 Threonine 3 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A1			[7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	593
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A1 Threonine 593 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	107
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A1 Tyrosine 107 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	317
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A1 Tyrosine 317 has the potential to affect its expression or activity.

References
1	The membrane topology of GAT-1, a (Na+ + Cl-)-coupled gamma-aminobutyric acid transporter from rat brain. J Biol Chem. 1997 Jan 10;272(2):1203-10.
2	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3	Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal. 2010 Jan 12;3(104):ra2.
4	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5	Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. Cell Metab. 2015 Nov 3;22(5):922-35.
6	Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol. 2013 Nov;14(11):1166-72.
7	Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome. Proteomics. 2015 Jan;15(2-3):500-7.
8	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
9	Substrate-induced regulation of gamma-aminobutyric acid transporter trafficking requires tyrosine phosphorylation. J Biol Chem. 2001 Nov 16;276(46):42932-7.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence